Novo Nordisk | NVO - 資産





資産 変化する 日付
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Bausch Health Companies USD 24.5B 1.87B 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Canopy Growth CAD 1.11B 36.35M 2025-12
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Drreddys Laboratories INR 6.26B 161.9M 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Merck USD 128.68B 8.18B 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 118.53B 7.58B 2026-03
Novo Nordisk DKK 559.22B 16.32B 2026-03
Novo Nordisk DKK 76.18B 412.98B 2025-06
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 7.98B 551.9M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Prestige Brands USD 3.49B 430K 2026-03
Sanofi EUR 128.02B 1.22B 2026-03
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
Zoetis USD 15.15B 313M 2026-03